President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for lowering drug costs. Trump's action didn't affect the caps on seniors' drug costs or Medicare price negotiations that Biden signed into law.

January, the Biden administration released its proposed Medicare Advantage rates in 2026. These are the rates that the government pays insurers for the program to provide low-cost, affordable plans for seniors.

Early moves by the president raise questions about what direction his second-term policy on drug costs will take.

Reforms of prescription drug pricing are finally taking full effect, just in time for Donald Trump and the Republicans to wreck them.

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

to develop and test ways to lower drug prices for people on Medicare and Medicaid. Since former-President Joe Biden's 2022 order, CMS had been planning out and preparing to test three models to lower prices. None of them had fully gone into effect.

On Day 1 of his second term of office, Trump rescinded Biden's Executive Order 14087, "Lowering Prescription Drug Costs for Americans." Trump's action ha

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department secretary to consider "new health care payment and delivery models" for the Center for Medicare and Medicaid Innovation to test.

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — posted to the Bluesky social media platform.

If public opinion polls are the guide, Joe Biden has been the worst president since Richard Nixon. Here's why that may be true.

Biden's administration announced weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations.

The White House on Tuesday is pausing federal grants and loans as President Donald Trump’s administration begins an across-the-board ideological review of its spending.